HemostOD
Latest round
- Seed
Last raised
- Oct 2025
Total raised
- $5.4M
Investors
- 2
About HemostOD
HemostOD SA, founded in 2020 in Switzerland, focuses on creating engineered platelets for therapeutic applications.HemostOD specializes in the engineering and manufacturing of universal platelets through its proprietary CAR-PLT technology, addressing critical healthcare challenges such as thrombocytopenia and HLA immune-refractoriness. Their core offerings include targeted delivery of therapeutic cargo, platelet lysate for therapeutic stem cell proliferation, and applications in wound healing, immunomodulation, and anti-inflammatory contexts.The company operates a B2B model, generating revenue through agreements for the production and supply of engineered platelets. Revenue is also anticipated from joint ventures and collaborations, which may include licensing agreements and service contracts tailored to client needs.3 million in October 2025, HemostOD plans to enhance production capacity of lab-made platelets and prepare for early-stage regulatory requirements. The company is targeting expansions into new geographic markets, particularly in Europe and North America, aiming to increase their footprint within the biopharmaceutical sector.
Who invested in HemostOD
2 investors across 1 round
See all investors in HemostOD
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Oct 1, 2025
Amount
$5.4M
Investors
Questions about HemostOD
Who invested in HemostOD?
HemostOD has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has HemostOD raised?
HemostOD has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did HemostOD last raise money?
HemostOD's most recent round on record is a Seed, in Oct 2025.
What does HemostOD do?
HemostOD SA, founded in 2020 in Switzerland, focuses on creating engineered platelets for therapeutic applications.
Where is HemostOD headquartered?
HemostOD is headquartered in Switzerland.
Which VCs invest in companies like HemostOD?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back medical devices & equipment companies at HemostOD's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Seed
Raising like HemostOD? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.